Evidence map›Paper›PMID 39684459›Full record

ArticleInternational journal of molecular sciences2024

Teratoma Development in 129.MOLF-Chr19 Mice Elicits Two Waves of Immune Cell Infiltration.

Lucas Klaus, Sybille D Reichardt, Maria Neif, Lutz Walter, Fabian A Gayer, Holger M Reichardt

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucas KlausInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Sybille D ReichardtInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Maria NeifInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Lutz WalterGerman Primate Center, Leibniz Institute for Primate Research, 37077 Göttingen, Germany.
Fabian A GayerInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Göttingen, Germany.
Holger M ReichardtInstitute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Göttingen, Germany.ORCID 0000-0003-4647-057X

Funding

Deutsche Forschungsgemeinschaft GA 3619/2-1Deutsche Forschungsgemeinschaft RE 1631/21-1
6 · The paper itself

Abstract

Teratomas are a highly differentiated type of testicular germ cell tumors (TGCTs), the most common type of solid cancer in young men. Prominent inflammatory infiltrates are a hallmark of TGCTs, although their compositions and dynamics in teratomas remain elusive. Here, we reached out to characterize the infiltrating immune cells and their activation and polarization state by using high-throughput gene expression analysis of 129.MOLF-Chr19 mice that spontaneously develop testicular teratomas. We showed that inconspicuous testes without any apparent alterations in size or morphology can be clustered into three groups based on their expression of stemness and immune genes, supporting a model in which initial oncogenic transformation elicits a first wave of T-cell infiltration. Moderately and severely enlarged tumorous testes then displayed a progressive infiltration with T cells, monocytes/macrophages, and B cells. Importantly, T cells seem to adopt an inactive state caused by an overexpression of immune checkpoint molecules and the polarization of monocytes/macrophages to an anti-inflammatory phenotype. Our findings are supported by the analysis of metabolic gene expression, which unveiled alterations indicative of tumor growth and immune cell infiltration. Collectively, testicular teratomas, at least in mice, are characterized by a diverse inflammatory infiltrate containing T cells that putatively become inactivated, allowing the tumors to further grow. We believe that these findings may provide a rationale for the development of new immunomodulatory therapies for TGCTs.

Indexed as

TeratomaTesticular NeoplasmsAnimalsDisease Models, AnimalGene Expression Regulation, NeoplasticMacrophagesMaleMiceNeoplasms, Germ Cell and EmbryonalTestisT-LymphocytesmacrophagesT cellsteratomatesticular germ cell tumortumor microenvironment

Identifiers

PMID39684459
PMCPMC11640870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.